These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe hemolytic disease of the newborn due to anti-Js(b). Gordon MC; Kennedy MS; O'Shaughnessy RW; Waheed A Vox Sang; 1995; 69(2):140-1. PubMed ID: 8585197 [TBL] [Abstract][Full Text] [Related]
3. [Isoimmunization to Kell factor, during pregnancy]. Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245 [No Abstract] [Full Text] [Related]
5. Severe haemolytic disease of the newborn due to anti-Js(b). Stanworth S; Fleetwood P; de Silva M Vox Sang; 2001; 81(2):134-5. PubMed ID: 11555475 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708 [TBL] [Abstract][Full Text] [Related]
7. [Hemolytic disease of the newborn due to Kell sensitization]. Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365 [No Abstract] [Full Text] [Related]
8. Haemolytic disease of the newborn due to anti-K antibodies. de Jonge N; Martens JE; Milani AL; Krijnen JL; van Krimpen C; Ponjee GA Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):69-72. PubMed ID: 8789754 [TBL] [Abstract][Full Text] [Related]
9. First case of hemolytic disease of the newborn due to anti-Ula antibodies. Sakuma K; Suzuki H; Ohto H; Tsuneyama H; Uchikawa M Vox Sang; 1994; 66(4):293-4. PubMed ID: 8079454 [TBL] [Abstract][Full Text] [Related]
10. [Hemolytic disease of the newborn due to anti-Ku (author's transl)]. Huang HJ; Tagawa H Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551 [No Abstract] [Full Text] [Related]
11. Dangers of anti-Kell in pregnancy. Lancet; 1991 Jun; 337(8753):1319-20. PubMed ID: 1674303 [No Abstract] [Full Text] [Related]
12. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940 [TBL] [Abstract][Full Text] [Related]
13. Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen. Scharberg EA; Wieckhusen C; Luz B; Rothenberger S; Stürzel A; Rink G; Richter E; Delle Chiaie L; Burgos A; Lomas-Francis C; Bugert P Transfusion; 2017 Jan; 57(1):217-218. PubMed ID: 27679424 [No Abstract] [Full Text] [Related]
14. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management. Wenk RE; Goldstein P; Felix JK Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011 [TBL] [Abstract][Full Text] [Related]
15. Kell sensitization in pregnancy. Caine ME; Mueller-Heubach E Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507 [TBL] [Abstract][Full Text] [Related]
16. Haemolytic disease of the newborn due to anti-k. Duguid JK; Bromilow IM Vox Sang; 1990; 58(1):69. PubMed ID: 2316215 [No Abstract] [Full Text] [Related]
17. Current clinical management of anti-Kell alloimmunization in pregnancy. Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801 [TBL] [Abstract][Full Text] [Related]